BIO Commends Selection of Kappos to Lead PTO

WASHINGTON, D.C. (Friday, June 19, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today in response to President Obama’s nomination of David J. Kappos for Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO):


“We commend President Obama for making a strong choice in his nomination of David Kappos.


“We believe Mr. Kappos will bring a thoughtful perspective to the Department of Commerce and the USPTO.  He has a long history of industry experience, providing a point of view and insights we have always thought to be highly valuable in this position.  He also has a demonstrated track record of managing a large organization, and a true appreciation for industrial innovation.


“As a prominent and respected member of the patent community, Mr. Kappos brings much goodwill to this position.  We look forward to working with him and his leadership team over the coming years.


“We urge the Senate to move quickly to consider Mr. Kappos’ nomination.  The USPTO needs a confirmed leader as soon as possible."

Upcoming BIO Events

World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada 

BIO Investor Forum
October 28-29, 2009
San Francisco, CA

Advanced Business Development Course
October 30, 2009
Vienna, Austria

BIO Europe International Partnering Conference
November 2-4, 2009
Vienna, Austria

Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 8-11, 2009
Honolulu, HI 

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.